Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by ifsoon Aug 06, 2021 8:03pm
67 Views
Post# 33667588

RE:RE:2 months of cash with no bridge loan

RE:RE:2 months of cash with no bridge loanThomvest was certainly more than happy the way Black Mamba helped the value of Prometic fall like it did. (My imagination run wild)
stockbuphoon wrote: Figure out what Thomvest is doing... pulled 4050 IPF/ hypertriglycemdia and 4527 in 2020. Shelved Alstrom. Analysts have nothing to use for potential markets for any price targets even if something did make it through clinical trials and gets approved.


<< Previous
Bullboard Posts
Next >>